Alerts will be sent to your verified email
Verify EmailFILTRA
Filtra Consultants
|
Dhanalaxmi Roto Spin
|
Biogen Pharmachem
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
14.65 % | 20.43 % | 0.21 % |
5yr average Equity Multiplier
|
1.87 | 1.65 | 1.01 |
5yr Average Asset Turnover Ratio
|
2.4 | 2.43 | 0.02 |
5yr Avg Net Profit Margin
|
3.25 % | 5.25 % | -19.83 % |
Price to Book
|
0.0 | 1.34 | 0.86 |
P/E
|
26.7 | 7.59 | 64.74 |
5yr Avg Cash Conversion Cycle
|
27.67 Days | 8.07 Days | 0.0 |
Inventory Days
|
52.76 Days | 4.2 Days | 0.0 |
Days Receivable
|
31.44 Days | 51.03 Days | 0.0 |
Days Payable
|
64.82 Days | 42.28 Days | 1109.22 Days |
5yr Average Interest Coverage Ratio
|
63.11 | 13.94 | 902.8 |
5yr Avg ROCE
|
20.36 % | 29.7 % | 0.21 % |
5yr Avg Operating Profit Margin
|
4.36 % | 4.13 % | -19.88 % |
5 yr average Debt to Equity
|
0.02 | 0.1 | 0.0 |
5yr CAGR Net Profit
|
13.93 % | 16.09 % | n/a |
5yr Average Return on Assets
|
7.86 % | 12.42 % | 0.21 % |
Shareholdings
|
|||
Promoter Holding
|
72.45 % | 47.64 % | 0.0 |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
-0.73 % | 0.0 | 0.0 |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Filtra Consultants
|
Dhanalaxmi Roto Spin
|
Biogen Pharmachem
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|